This cluster is routine and non-informative, low dollar values relative to market cap and the Director's sale coincides with a same-day option exercise, typical of tax/estate planning. No bearish read-through warranted. Monitor the next quarterly filing for any change in operating trends.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 10 $27.49entry
- T+1 · 4mo ago +1.46%α +2.22% · $27.89
- T+5 · 4mo ago −2.15%α −0.60% · $26.90
- T+20 · 3mo ago −18.33%α −20.76% · $22.45
- T+60 · 6w ago −25.61%α −28.24% · $20.45
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two insiders at Privia Health sold shares in early July 2026, totaling ~$1.48M. The largest sale was a Director's open-market disposition of $1.46M, executed simultaneously with a derivative exercise, while the CFO sold a de minimis $17K worth of shares. This is a modest insider selling cluster, the total value is about 0.04% of the $3.4B market cap, well below the 0.1% materiality threshold, and likely reflects routine portfolio management, not a bearish signal on the company's outlook.
Key Financial Metrics
Key Facts
- Director Matthew Shawn Morris sold 53,722 shares on July 6 at ~$27.24, netting $1.46M.
- Morris also exercised derivatives for 53,722 shares on the same date, the sale appears to be a same-day cashless exercise-and-sell.
- CFO David Mountcastle sold 600 shares on July 7 at $27.57 for $16,542, a trivial amount.
- Total insider selling value of ~$1.48M represents approximately 0.04% of Privia's $3.4B market cap.
- No open-market insider buying was recorded in this cluster.
Financial Impact
Total insider sales of $1.48M, 0.04% of market cap, immaterial to company valuation.
Risk Factors
- Insider selling patterns can escalate, watch for larger or repeated sales by the CEO/CFO in subsequent weeks.
- Director Morris's large derivative exercise could signal upcoming open-market sales if the exercised shares are held for less than 6 months.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PRVA-1783670735774 |
Track record
20 reports on PRVA
4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +10.73% at T+60 after the Mar 9, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Mixed 6/10 No price data
- Nov 5, 202611d ago Press Release Bearish 5/10 Entry $23.94 to $23.67 Now $25.26 −5.51% ▲ +1.13% +4.42% vs SPY
- Nov 2, 202614d ago Press Release Neutral 3/10 Entry $21.28 to $24.54 Now $25.26 +18.70% ▲ +15.32% +15.24% vs SPY
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $21.48 to $24.42 Now $25.26 +17.60% ▲ +13.69% +16.39% vs SPY
- Oct 7, 20265w ago SC 13G/A Neutral 3/10 Entry $20.30 to $21.67 Now $25.26 +24.43% ▲ +6.75% +7.73% vs SPY
- Jul 13, 202618w ago Insider Cluster Neutral 3/10 Entry $28.03 to $26.26 Now $25.26 −9.88% ▼ −6.31% −5.02% vs SPY
- Jul 9, 202618w ago Insider Cluster Neutral 3/10 Viewing Entry $27.49 to $26.90 Now $25.26 −8.11% ▼ −2.15% −0.60% vs SPY
- Jul 7, 202618w ago Insider Cluster Neutral 3/10 Entry $27.21 to $28.10 Now $25.26 −7.17% ▲ +3.27% +2.01% vs SPY
- Jul 7, 202618w ago Press Release Neutral 1/10 Entry $27.23 to $28.03 Now $25.26 −7.23% ▲ +2.94% +2.39% vs SPY
- Jul 2, 202619w ago Insider Cluster Neutral 3/10 Entry $27.36 to $27.77 Now $25.26 −7.68% ▲ +1.50% +0.57% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers